EUDA Health Holdings Limited (EUDA)
NASDAQ: EUDA · Real-Time Price · USD
4.530
-0.130 (-2.79%)
Nov 22, 2024, 4:00 PM EST - Market closed
EUDA Health Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 3.81 | 3.71 | 3.76 | 4.56 | 8.88 |
| Revenue Growth (YoY) | -57.04% | -1.54% | -17.42% | -48.64% | - |
| Cost of Revenue | 2.97 | 2.86 | 2.89 | 3.31 | 4.99 |
| Gross Profit | 0.84 | 0.84 | 0.87 | 1.25 | 3.89 |
| Selling, General & Admin | 3.68 | 4.8 | 6.75 | 1.81 | 4.63 |
| Research & Development | - | - | - | - | 0.16 |
| Other Operating Expenses | - | - | 5.2 | - | - |
| Operating Expenses | 3.68 | 4.8 | 11.95 | 1.81 | 4.78 |
| Operating Income | -2.83 | -3.96 | -11.08 | -0.56 | -0.89 |
| Interest Expense | -0.06 | -0.02 | -0.09 | -0 | -0.07 |
| Interest & Investment Income | - | - | - | 1.92 | - |
| Other Non Operating Income (Expenses) | 0.11 | -3.8 | -12.72 | 0.31 | 1.09 |
| EBT Excluding Unusual Items | -2.79 | -7.79 | -23.89 | 1.67 | 0.13 |
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.11 |
| Asset Writedown | -14.76 | - | -1.14 | - | - |
| Other Unusual Items | -0.45 | -0.65 | - | - | - |
| Pretax Income | -17.99 | -8.43 | -25.03 | 1.67 | 0.25 |
| Income Tax Expense | -0 | - | -0.02 | 0.05 | 0.05 |
| Earnings From Continuing Operations | -17.99 | -8.43 | -25.01 | 1.62 | 0.2 |
| Earnings From Discontinued Operations | -0.36 | -1.6 | 0.06 | -0.72 | - |
| Net Income to Company | -18.36 | -10.04 | -24.95 | 0.9 | 0.2 |
| Minority Interest in Earnings | 0 | -0 | 0.07 | -0.04 | -0.02 |
| Net Income | -18.35 | -10.04 | -24.88 | 0.86 | 0.18 |
| Net Income to Common | -18.35 | -10.04 | -24.88 | 0.86 | 0.18 |
| Net Income Growth | - | - | - | 392.57% | - |
| Shares Outstanding (Basic) | 27 | 23 | 12 | 9 | 1 |
| Shares Outstanding (Diluted) | 27 | 23 | 12 | 9 | 1 |
| Shares Change (YoY) | 79.65% | 90.37% | 30.00% | 825.33% | - |
| EPS (Basic) | -0.69 | -0.44 | -2.07 | 0.09 | 0.18 |
| EPS (Diluted) | -0.69 | -0.44 | -2.07 | 0.09 | 0.18 |
| EPS Growth | - | - | - | -46.77% | - |
| Free Cash Flow | -2 | -2.92 | -1.53 | 0.44 | -0.49 |
| Free Cash Flow Per Share | -0.08 | -0.13 | -0.13 | 0.05 | -0.49 |
| Gross Margin | 22.05% | 22.72% | 23.11% | 27.42% | 43.83% |
| Operating Margin | -74.37% | -106.87% | -294.35% | -12.28% | -10.07% |
| Profit Margin | -481.52% | -270.86% | -661.06% | 18.97% | 1.98% |
| Free Cash Flow Margin | -52.47% | -78.72% | -40.56% | 9.71% | -5.50% |
| EBITDA | -2.82 | -3.95 | -10.95 | -0.38 | -0.67 |
| EBITDA Margin | -73.93% | -106.52% | -290.91% | -8.42% | -7.54% |
| D&A For EBITDA | 0.02 | 0.01 | 0.13 | 0.18 | 0.22 |
| EBIT | -2.83 | -3.96 | -11.08 | -0.56 | -0.89 |
| EBIT Margin | -74.37% | -106.87% | -294.35% | -12.28% | -10.07% |
| Effective Tax Rate | - | - | - | 2.78% | 19.26% |
| Revenue as Reported | 3.81 | 3.71 | 3.76 | 4.56 | 8.88 |
| Advertising Expenses | - | 0.46 | 0.86 | 0.27 | 0.17 |
Source: S&P Capital IQ. Standard template. Financial Sources.